Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04068805 · ClinicalTrials.gov registry record · NA
Developing Affective HeaLth to Improve Adherence to Health Behaviors in Diabetes (DAHLIA II)
A NA study, sponsored by Happify.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04068805: Clinical Trial NA study, sponsored by Happify.
NCT04068805 is a NA study that was terminated before completion, run by Happify. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04068805, a NA study, was terminated before completion, sponsored by Happify.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Participants will be randomly assigned to either a positive affect skills intervention or a psychoeducation control group and assessed with questionnaires before, during, and after the 8-week program, as well as at 3 months, 6 months, and 12 months after the end of the program.
Primary Outcome
1-item self-reported measure of Hemoglobin A1C (HbA1C) level, "What was your most recent HbA1c level?"
Interventions
- BEHAVIORAL Happify
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-08-31 |
| Est. Completion | 2022-07-12 |
| Phase | NA |
Why NCT04068805 stopped before completion
NCT04068805 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Happify is the first listed.
NCT04068805 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04068805 about?
NCT04068805 is a clinical study titled "Developing Affective HeaLth to Improve Adherence to Health Behaviors in Diabetes (DAHLIA II)". Participants will be randomly assigned to either a positive affect skills intervention or a psychoeducation control group and assessed with questionnaires before, during, and after the 8-week program, as well as at 3 months, 6 months, and 12 months after the end of the program.
What is the current status of trial NCT04068805?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2020-08-31. Estimated completion is 2022-07-12.
What interventions are being tested in trial NCT04068805?
The interventions under investigation include: Happify (BEHAVIORAL).
Who is sponsoring clinical trial NCT04068805?
This trial is sponsored by Happify, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04068805's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy